Updated Sep 18
Oct 14, 2026
AI Answers Are Swallowing the Click, and the Tools Built to Track Them Are Changing Shape
For most of the last two years, the pitch for “AI visibility” software was simple: find out whether ChatGPT mentions you. Plug in a domain, get a chart. That part is more or less solved. The harder question, the one marketing teams keep raising in Slack threads and quarterly reviews, is what you’re supposed to do once the chart comes back red. A newer kind of vendor is trying to answer it.
tech industry
Sep 30, 2026
How to Track AI Visibility in ChatGPT, Gemini & More
Learn how to track AI visibility step by step: pick the right prompts, measure mentions, citations and sentiment, and see why Promptwatch is the best tool.
tech industry
Sep 30, 2026
ChatGPT Space replaces Library for eligible users, while Projects stay separate
OpenAI's DevDay launch gives teams a shared home for pages and files. The current help guide draws important lines around Projects, mobile editing, inherited access and automatic page updates.
OpenAIChatGPTSpace
Related News
Oct 25, 2026
Anthropic invites life-science labs to propose short research collaborations with Claude
The guest-investigator program offers selected research groups direct collaboration and no-cost use of Anthropic’s models and harnesses. Applications should use public information, and projects must target a concrete deliverable within 8–12 weeks.
AnthropicClaudeLife sciences
Oct 9, 2026
Claude Found a Phage Pattern. Ten Repeat Searches Missed It
Anthropic's ART preprint records one Claude agent finding an overlooked DNA-repeat pattern, while ten repeat campaigns missed it. The difference exposes a practical limit in tool-using research agents: having the right files is not the same as reading the decisive evidence.
ClaudeAnthropicAI research
Sep 28, 2026
AI found a thermostable mRNA vaccine recipe in six rounds—but the evidence is still preclinical
A peer-reviewed MIT study used Bayesian optimization to find solid-state mRNA vaccine formulations that retained full bioactivity after more than two months at 37°C and produced non-inferior immune responses in reported animal experiments.
AI researchmRNA vaccinesbiotechnology